QuatRx Pharmaceuticals Presents Results from Ophena Phase 3 Study

ANN ARBOR, MI-QuatRx Pharmaceuticals today announced detailed primary endpoint results from a pivotal Phase 3 clinical trial of OphenaTM (ospemifene tablets) to treat postmenopausal women with symptoms of vulvovaginal atrophy, a common condition associated with menopause. The study successfully met all four co-primary endpoints. Women treated with OphenaTM at the 60 mg dose showed statistically [.. more ..]

Berriz Winner of 2008 Ernst & Young Master Entrepreneur Award

ANN ARBOR, MIGHIGAN - JUNE 14, 2008 - The 22nd Annual Ernst & Young Entrepreneur Of the Year Award Ceremony for the Central Great Lakes Division Announced Albert M. Berriz, Chief Executive Officer of McKinley, Inc., as Master Entrepreneur for 2008. The award ceremony was held at the Ritz-Carlton, Dearborn on June 12, 2008.
Albert M. [.. more ..]

Who links to my website?